Copyright
©The Author(s) 2020.
World J Clin Cases. Jul 26, 2020; 8(14): 2917-2929
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2917
Published online Jul 26, 2020. doi: 10.12998/wjcc.v8.i14.2917
Figure 7 Knockdown of APEX2 can suppress the CCNB1 and MYC pathways.
A: HCCLM3 cells were transfected with siRNA against APEX2 and scramble control, and the CCNB1, B: MYC mRNA level were analyzed by qPCR assay; D: The promoter transcription activity of CCNB1 and D: MYC were analyzed by dual-luciferase reporter assay. siRNA: Small interfering RNA; siCon: Scramble control sequence.
- Citation: Zheng R, Zhu HL, Hu BR, Ruan XJ, Cai HJ. Identification of APEX2 as an oncogene in liver cancer. World J Clin Cases 2020; 8(14): 2917-2929
- URL: https://www.wjgnet.com/2307-8960/full/v8/i14/2917.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i14.2917